New cholesterol drug inclisiran tested in Real-World spanish patients

NCT ID NCT06958315

Recruiting now Disease control Sponsor: Novartis Pharmaceuticals Source: ClinicalTrials.gov ↗

First seen Jan 11, 2026 · Last updated May 24, 2026 · Updated 16 times

Summary

This study follows 200 adults in Spain who are already taking inclisiran (Leqvio) for heart disease or a genetic high-cholesterol condition. Researchers want to see if the drug helps patients reach their LDL cholesterol goals in everyday medical practice. The study is observational, meaning no new treatment is given—just data collection from routine care.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Locations

Novartis Investigative Site
RECRUITING

Cadiz, Andalusia, 11009, Spain
Novartis Investigative Site
RECRUITING

Granada, Andalusia, 18014, Spain
Novartis Investigative Site
RECRUITING

Huelva, Andalusia, 21005, Spain
Novartis Investigative Site
RECRUITING

Jaén, Andalusia, 23007, Spain
Novartis Investigative Site
RECRUITING

Marbella, Andalusia, 29600, Spain
Novartis Investigative Site
RECRUITING

Mallorca, Balearic Islands, 07198, Spain
Novartis Investigative Site
RECRUITING

Puerto Real, Cadiz, 11510, Spain
Novartis Investigative Site
RECRUITING

Santander, Cantabria, 39008, Spain
Novartis Investigative Site
RECRUITING

Andújar, Jaen, 23740, Spain
Novartis Investigative Site
RECRUITING

Logroño, La Rioja, 26006, Spain
Novartis Investigative Site
RECRUITING

San Cristóbal de La Laguna, Santa Cruz De Tenerife, 38320, Spain
Novartis Investigative Site
RECRUITING

Burgos, 09006, Spain
Novartis Investigative Site
RECRUITING

Córdoba, 14004, Spain
Novartis Investigative Site
RECRUITING

Fuerteventura, 35600, Spain
Novartis Investigative Site
RECRUITING

Las Palmas GC, 35010, Spain
Novartis Investigative Site
RECRUITING

León, 24080, Spain
Novartis Investigative Site
RECRUITING

Málaga, 29010, Spain
Novartis Investigative Site
RECRUITING

Salamanca, 37007, Spain
Novartis Investigative Site
RECRUITING

Seville, 41009, Spain
Novartis Investigative Site
RECRUITING

Seville, 41013, Spain

Conditions

Explore the condition pages connected to this study.

ATHEROSCLEROTIC VASCULAR DISEASE HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA